Research Volunteers Needed
ADHD | Addictions | Alcohol | Anorexia | Autism | Eating Disorders | Healthy Volunteers | Memory Disorders | Mood Disorders | Obesity | Pain | Parkinson's Disease | Psychosis and Schizophrenia | Substance Abuse - Addictions
Studies with children and adolescent research participants »
Adults with Autism Spectrum Disorder (ASD) Needed for Cannabidiol (CBD) Research
People 18 years or older with ASD and who have a significant mood disorder or other behaviors that interfere with function and quality of life are needed to take part in a Johns Hopkins research study. The study will last 14 weeks total, during which six weeks participants will receive a pill containing CBD, one to two weeks where participants will receive no drug/placebo, and six weeks where participants will receive the placebo, an inactive pill. As part of the study, participants will have regular visits and be asked questions about anxiety, challenging behaviors, daily functioning, cognition, and physical symptoms, on standard assessments that are not usually asked in routine clinical care. Call 410-575-3267 or email [email protected] for details. Principal Investigator: Elizabeth Wise, MD (IRB00267739)
ADHD - Attention Deficit Hyperactivity Disorder
Adult ADD/ADHD
Men and women who have been diagnosed with ADD or ADHD are needed for a 2-day outpatient study at the Johns Hopkins School of Medicine in Baltimore, Maryland. Volunteers with ADHD who have used medications for the treatment of ADHD and those who have never used medications for the treatment of ADHD are needed. Volunteers should be between the ages of 18 and 40 and in general good health. Testing will take place at the Johns Hopkins Hospital and Bayview Medical Center. Study participants will receive compensation, and travel expenses will be covered. Earn up to $300 plus travel expenses. For more information, call 410-550-2588 or 410-550-5295 or email [email protected]. Collect calls are accepted. Principal Investigator: Una D. McCann, MD (IRB Number: NA_0073552)
Alcohol
Related studies:
Anorexia
This research study examines “interoception” — your ability to perceive internal sensations. Across four visits, participants will do computer tasks, undergo an MRI scan, and engage in breathing exercises and mindfulness meditation in virtual reality. We aim to characterize the ability of adolescents with OCD, anxiety, and anorexia to sense their internal state, compared to adolescents without these conditions. Eligible participants must be 12-17 years old, have a diagnosis of anorexia nervosa, OCD, or anxiety, be fluent in English, be right-handed, and be able to undergo an MRI scan. Participants can earn up to $200 in compensation. For more information, go to jhucoach.org/vitals, email [email protected], or call (443)-300-8836. Principal Investigator: Joseph McGuire, Ph.D.
Eating Disorders
Related studies:
Memory Disorders
Phase II Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
We are doing this study to better understand the link between stress and memory problems. When individuals are in stressful situations, their bodies make “stress” hormones that can have negative effects on brain areas that control memory. Individuals with Alzheimer’s disease have higher levels of stress hormones than individuals without this disease.
In this study, we are testing the effects of a new drug, called CORT108297, which was developed to block stress hormones from attaching to brain areas related to memory. Our goal is to determine whether this drug is effective in improving memory in individuals with memory impairment and/or in those who have no memory impairment but are at risk for Alzheimer’s disease.
This study will involve 6 in-person visits over 10 weeks at the Johns Hopkins Bayview campus. Participants with mild cognitive impairment or who have risk factors for Alzheimer’s disease, and who are at least 55 years old, can participate. To hear more information regarding this study, please call us at (410) 550-2036 or email study coordinator Nick Bienko at [email protected]. Principal investigator: Cynthia A. Munro, Ph.D. (IRB00227116).
Psilocybin is being studied as a potential aid for Depression in Early Alzheimer's Disease
Have you recently been diagnosed with Alzheimer’s Disease? Are you feeling depressed? Sign up to participate in a research study examining a unique approach to depression in people with Mild Cognitive Impairment (MCI) or early Alzheimer’s Disease (AD).
Researchers at Johns Hopkins University are studying psilocybin – a psychoactive substance found in certain kinds of mushrooms – to see whether it can help people with depression and Alzheimer’s Disease when administered in a safe and supportive setting. Volunteers will additionally receive free counseling.
To find out more about this study, call 410-550-5466. Download Flyer. Principal Investigators: Albert Garcia-Romeu, Ph.D. & Paul B. Rosenberg, M.D., Protocol: IRB00175915
Pilot Study of 5-HT2A Agonist Psilocybin for Depression in Patients with Mild Cognitive Impairment or Early Alzheimer’s Disease
Have you recently been diagnosed with Alzheimer’s Disease? Are you feeling depressed? Sign up to participate in a research study examining a unique approach to depression in people with Mild Cognitive Impairment (MCI) or early Alzheimer’s Disease (AD). Researchers at Johns Hopkins University are studying psilocybin – a psychoactive substance found in certain kinds of mushrooms – to see whether it can help people with depression and Alzheimer’s Disease when administered in a safe and supportive setting. Volunteers will additionally receive free counseling. To find out more about this study, visit our website: HopkinsPsychedelic.org/Alzheimers or call 410-550-1972. Principal Investigators: Albert Garcia-Romeu, Ph.D. and Paul B. Rosenberg, M.D., Protocol: IRB00175915
Circadian Rhythm Disturbance in Agitation of Alzheimer’s Disease (The Actigraphy in Agitation Study)
Agitation in Alzheimer’s disease can be challenging for affected individuals and the people who care for them. Some researchers think that agitation in Alzheimer’s disease may be caused by changes in a person’s normal sleep cycle. Individuals with these changes may become more likely to become restless, wander and pace, resist help with daily activities, or become hard to handle at certain times in the day. The goal of the Actigraphy in Agitation study is to learn more about changes in sleep patterns that occur in people with Alzheimer’s disease. The Actigraphy in Agitation study is looking for people who have Alzheimer’s disease with or without symptoms of agitation including pacing, resisting care, and restlessness. Participants in the Actigraphy in Agitation study will be asked to attend 1 clinic visit at Johns Hopkins at Bayview, wear a device the size of a wrist watch on their wrist for 7 days and use two devices to help researchers learn about their sleep patterns. The study team will provide all of the required equipment at no cost. If you are interested in learning more about this trial, please contact John Outen at 410-550-7385 or [email protected]. Principal Investigator: Paul Rosenberg, M.D. (JHU protocol number IRB00151016). Download flyer.
Problem Adaptation Therapy for Mild Cognitive Impairment and Depression (PATH-MCI)
Johns Hopkins Memory and Alzheimer’s Treatment Center is looking for volunteers to participate in a research study, called PATH-MCI, which is testing if psychotherapy intervention (also known as talk therapy) is effective in helping individuals with mild memory problems and depression symptoms with their cognition, mood, and function. If you are between the ages of 60-85 years old, diagnosed with mild memory problems and experience depression symptoms, you may be eligible for PATH-MCI. For more information or to see if you qualify, contact us at (410) 550-9022 or [email protected] (Principal Investigator: Paul Rosenberg, MD; Protocol number: IRB00063914)
Escitalopram for Agitation in Alzheimer’s Disease (S-CitAD)
Agitation is common in people who have Alzheimer’s disease (AD) and can be can be a challenging behavior for the family and friends of these individuals. Agitation affects 42-60 percent of people with Alzheimer’s Disease, and involves emotional distress, excess psychomotor activity, aggression, or disinhibition. Treatment options for agitation in AD are limited. Current approaches are inadequate and better approaches are needed. S-CitAD is a placebo-controlled, masked, randomized clinical trial, sponsored by the National Institute on Aging (NIA). The study is designed to examine the efficacy and safety of escitalopram in combination with a psychosocial intervention (PSI) as treatment for agitation in AD patients. Individuals in the S-CitAD trial will be enrolled for 24-weeks, with treatment for 12 weeks, and additional 12 weeks of safety and efficacy follow-up, for a total of 6 clinic visits at Johns Hopkins University. If you are interested in learning more about this trial, call (410) 550-9022. Site Investigator: Paul Rosenberg, MD. (Principal Investigator: Constantine Lyketsos, MD; Protocol number: IRB00148995)
Apathy in Dementia Study (ADMET II Trial)
Apathy is one of the most prevalent neuropsychiatric symptoms in individuals with Alzheimer’s disease.Up to 50% of people with dementia experience this loss of will and initiative, lack of interest in activities,lack of productivity, or lack of response to events in their life. The goal of the ADMET II study is to see ifmethylphenidate can help lessen the effects of apathy in Alzheimer’s disease. Also known as Ritalin, methylphenidate is approved for use in the treatment of attention Deficit/Hyperactivity Disorder by the FDA, and previous trials have suggested it may be helpful in treating apathy in Alzheimer’s disease. Individuals in the ADMET II trial will be asked to take methylphenidate or placebo for 6 months and attend about 7 clinic visits at Johns Hopkins at Bayview. If you are interested in learning more about this trial, call 410-550-9022. Principal Investigator: Paul Rosenberg, M.D. (JHU protocol number IRB00064958)
BDPP Treatment for Mild Memory Loss and PrediabetesThe combination of memory problems and abnormal blood sugar has been shown to be a risk factor for developing Alzheimer’s disease, and a nutraceutical (“health food”) is being investigated to target this problem. This trial is seeking individuals between the ages of 50-90 who are concerned that they may be experiencing memory loss. BDPP is a combination of resveratrol (a chemical found in the skin of grapes), grape seed extract, and Concord grape juice. Study investigators hope to learn if BDPP could help maintain memory or decrease the amount of abnormal proteins in the brain. Individuals in this study will be asked to take BDPP or placebo for 4 months and attend about 9 research visits to Johns Hopkins at Bayview. Glucose testing and a memory evaluation are provided as part of the trial. Please call 410-550-6486 for more information on how to enroll. Principal investigator: Paul Rosenberg, M.D. (IRB protocol number IRB00062802)
Memory & Aging Study
The Johns Hopkins Memory Center is currently conducting a study of the differences between normal aging, mild memory problems, and the onset of memory disorders like Alzheimer’s Disease. If you choose to participate in the Memory and Aging Study, you and a study partner will be invited to our clinic for a 2-3 hour assessment including memory testing, physical exam, and blood samples. We will ask you and your study partner questions about your daily functioning. You will return to our clinic once a year for an annual physical exam and memory testing. People, 60 years old or older, with or without memory problems, can participate in this study. If you are interested in learning more about this study please call Emily Braverman at 410-550-9021. Constantine Lyketsos, MD, MHS,, Principal Investigator (JHU IRB Application No: NA_00045104)
Related studies:
Mood Disorders
Johns Hopkins is seeking people who have a diagnosis of bipolar I disorder to participate in a research study.
The purpose of this study is to create a database of information that allows researchers to explore how genetics and other biomarkers are impacted by bipolar disorder and its treatment. This information will be useful in learning more about bipolar disorder and to assist in the development of individualized care. You may be eligible to participate if: You are 18-75 years of age; You have been diagnosed with bipolar I disorder. If you choose to participate in the study, you will be asked to complete four annual in-person study visits—consisting of cognitive assessments, blood draw, and an MRI scan—as well as to complete a series of short online surveys periodically over the course of four years. Compensation will be provided for your time. For more information, please contact a member of our study team. Phone: 410-701-0691, Email: [email protected]. Principal Investigator: Fernando Goes.
Bipolar Disorder study
Physician scientists in psychiatry and researchers are seeking adults who have diagnosis of Bipolar I or II to participate in a research study that looks for pathological mechanisms for the disorder. You will complete an over-the-phone interview to determine eligibility, and if qualified the study member will schedule a date for you to undergo a skin biopsy and blood draw. You will be compensated $200 once all study components are completed (interview, blood draw, biopsy). To learn more, please call Neal Prasad at 443-287-2981 or email at [email protected] (Principal Investigator: Akira Sawa, M.D., Ph.D., (IRB # NA_00037204)
Geriatric Depression Study
Are you over 60 and feeling depressed? Symptoms of depression in older adults are common yet often go undetected. Symptoms could include feelings of sadness or hopelessness, loss of energy, inability to enjoy pleasurable activities, changes in appetite or sleeping patterns, or poor concentration/memory. If you are feeling depressed, not taking antidepressant medication and in good physical health you may be eligible to participate in a research study involving treatment. Qualified people will participate at no cost to them and will be compensated for their time and transportation. For more information about the research study, please call us at 410-550-4192 or email us at [email protected] . Download PDF flyer. Principal Investigator:Gwenn Smith, PhD (IRB Protocol No: NA_00021615)
Related studies:
Pain
Sleep and Pain in Sickle Cell Disease
We are looking for men and women that are at least 18 years old and have been diagnosed with Sickle Cell Disease (SCD) to participate in a research study. The purpose of this study is to learn more about how SCD impacts sleep and pain. Study procedures include (but are not limited to): questionnaires, sensory testing, brain imaging, and sleep interventions with a trained clinician. Volunteers are asked to participate in 8 in-person visits and two follow-ups which will be done online. Participants will be paid up to $1,288 for completing all study procedures. For more information, please contact the Research Coordinator at 410-550-1217. Principal Investigator: Claudia Campbell, PhD (IRB0010060).
Knee Osteoarthritis
Do you have knee osteoarthritis? Researchers at Johns Hopkins are looking for volunteers to participate in a research study examining the effects of combining FDA-approved medications for reducing pain. To participate, you must be at least 45 years of age and have osteoarthritis in your knee. To see if you are eligible, you must complete one phone screen and one in-person screening visit. If you are eligible, the study involves 4 full-day sessions involving drug administration, sensory testing and cognitive testing. Compensation up to $1425. Please call today at 410.550.6240. Principal Investigator: Claudia Campbell, Ph.D. IRB00125605.
Parkinson's Disease
Molecular Imaging of Depression in Aging and Parkinson’s Disease
Are you over 55 and feeling depressed? Have you been diagnosed with Parkinson’s disease and are feeling depressed? Symptoms of depression in older adults are common yet often go undetected. Symptoms could include feelings of sadness or hopelessness, loss of energy, inability to enjoy pleasurable activities, changes in appetite or sleeping patterns, poor concentration/memory. If you are feeling depressed and are in good physical health, you may be eligible to participate in a research study involving treatment. Qualified people will participate at no cost to them, will be compensated for their time. Transportation will be provided. For more information about the research study, please call us at 410-550-4192 or email us at [email protected]. Principal Investigator: Gwenn Smith, PhD (IRB Protocol No: IRB00269869). Download flyer.
Psychosis and Schizophrenia
First Episode Psychosis: Longitudinal Characterization of Molecular Biomarker Changes Over the Early Course of Psychotic Disease
Researchers are seeking individuals diagnosed with a psychotic disorder to participate in a research study being done to study the cells of patients with psychotic disorders. Your participation may help improve the treatment of psychotic disorders for patients like you. This study is a longitudinal study over the course of three years (only a few visits required per year): you can earn up to $1740. To be eligible for this study, you must be between 13-35 years of age with a psychotic disorder diagnosis – this may include schizophrenia, bipolar disorder, and mood disorders. Qualified participants have the option of undergoing: blood draw, skin biopsy, nasal biopsy, lumbar puncture, and two sessions of brain scanning with MRI technology. To learn more, please call Maeve Schumacher at 410-502-2643 or email at [email protected] (NA_00082086, Principal Investigator: Akira Sawa, M.D.)
Cell and MRI Study of Patients with Schizophrenia
Do you have Schizophrenia? Are you between 18-65 years of age? You may be the perfect candidate for our study! Researchers are seeking individuals diagnosed with Schizophrenia to participate in a research study being done to study the cells of patients with schizophrenia. The study takes place over the course of two weeks, during which you can earn a compensation of up to $500! Qualified participants will have the option of undergoing neuropsychological testing with a study team member, a blood draw, a nasal biopsy, and three sessions of brain scanning using MRI technology. To learn more, please call Haydn Loudd at 410-502-2643 or email at [email protected] (Principal Investigator: Akira Sawa, M.D. (IRB # NA_00037204)
Substance Abuse/Addictions
Cigarette Smokers Needed
Adult cigarette smokers age 18-65 years old are needed to take part in a research study at the Johns Hopkins Bayview Medical Center.
We are seeking current cigarette smokers who are thinking about quitting. Participants will be paid up to $615 for study completion. The study involves taking cannabidiol (CBD) in different doses over the course of 6 weeks while completing brief practice quit attempts. There is also a separate 2-3 hour screening visit to determine eligibility. Call (410) 550-5143 or https://jhmi.co1.qualtrics.com/jfe/form/SV_0qAxNqYJKK8zOMm for details.
Principal Investigator: Dustin Lee, PhD IRB00170600
Examining pharmacokinetic and pharmacodynamics of “tobacco-free” oral nicotine pouches
Dr. Tory Spindle and colleagues at the Behavioral Pharmacology Research Unit are recruiting healthy adults at least 21 years old to take part in a Johns Hopkins research study. We are seeking people who currently smoke cigarettes and are not seeking treatment to quit smoking. The study will require 8 total visits to the lab (located at the Bayview Medical Center). Participants will first complete an in-person screening session (lasting about 2 hours) to determine study eligibility. Participants who are eligible and agree to be in the study will use nicotine pouches of different nicotine strengths and flavors as well as cigarettes in 7 different lab sessions that will each last about 5 hours. Study completers can earn up to $1,030. To see if you may be eligible, click here: https://jhmi.co1.qualtrics.com/jfe/form/SV_efBqv2b4uwNaKlo Or call: (410) 550-0050. Download flyer. Principal Investigator: Tory Spindle, Ph.D. IRB00318560
Methamphetamine Users
Methamphetamine users are needed for a medical research study. Volunteers should be between the ages of 18-45, in good general health and taking no regular medications. Testing will take place at the Johns Hopkins Bayview Medical Center and the Johns Hopkins Hospital in Baltimore, MD. Volunteers will be paid for completion of all study procedures. Travel expenses will be covered. Please call 410-550-2588 or 410-550-5295 or email [email protected] for more information. Principal Investigator: Una D. McCann (IRB Number: NA_00031313)
Related studies:
Healthy Research Volunteers Needed
Participants needed for sleep disruption studies
Individuals who have previously taken an opioid medication and are healthy, good sleepers are needed to participate in a research study. Participation involves in-home sleep screening, sensory testing, opioid medication and/or placebo exposure, and monitored overnight stays at the clinical research unit. Eligible participants may be compensated up to $1205.00. If interested in participating, please contact the Behavioral Medicine Research Lab at [email protected] or (410) 550-6246. Michael Smith, Ph.D., Principal Investigator, Johns Hopkins University School of Medicine, Protocol: IRB00224309, Protocol: IRB00160629. Download flyer
Adults
Phase II Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
We are doing this study to better understand the link between stress and memory problems. When individuals are in stressful situations, their bodies make “stress” hormones that can have negative effects on brain areas that control memory. Individuals with Alzheimer’s disease have higher levels of stress hormones than individuals without this disease.
In this study, we are testing the effects of a new drug, called CORT108297, which was developed to block stress hormones from attaching to brain areas related to memory. Our goal is to determine whether this drug is effective in improving memory in individuals with memory impairment and/or in those who have no memory impairment but are at risk for Alzheimer’s disease.
This study will involve 6 in-person visits over 10 weeks at the Johns Hopkins Bayview campus. Participants with mild cognitive impairment or who have risk factors for Alzheimer’s disease, and who are at least 55 years old, can participate. To hear more information regarding this study, please call us at (410) 550-2036 or email study coordinator Nick Bienko at [email protected]. Principal investigator: Cynthia A. Munro, Ph.D. (IRB00227116).
Related studies:
Oxidative Stress and Mood Disorder Trajectories Research Study
This research study will involve 2 study visits over a period of 2 weeks consisting of a blood draw, a urine tox screen, psychiatric evaluations, answering questionnaires and undergoing a scan of your brain called magnetic resonance imaging (MRI). People aged 35-84 years with and without mood disorders may participate. Principal Investigator: Fernando Goes, MD; IRB00104809.
Does Your Sense of Taste Affect Your Appetite?
Healthy participants between the ages of 18 and 65 are needed to take part in a research study at Johns Hopkins Bayview Medical Center. The study will examine participants' appetite and ability to taste before and after taking a drug. Participation involves one screening visit and three study days that may last up to five hours each. Participants will earn up to $180. For more information or to enroll, please call 410-550 -1102. Refer to the "Taste" study. Principal Investigator: Denis Antoine, M.D.( Application #: NA_00046407)
Healthy Volunteers/Adult ADD/ADHD
Healthy men and women are needed to take part in a 2-day outpatient study at the Johns Hopkins School of Medicine. Volunteers should be between the ages of 18 and 40 and in good general health. The study involves neuropsychological questionnaires and brain imaging scans. Testing will take place at the Johns Hopkins Hospital and Bayview Medical Center. Volunteers will be paid for completion of all study procedures. Earn up to $300 plus travel expenses. For more information please call 410-550-6266 or 410-550-2588 or email [email protected]. Principal Investigator: Una D. McCann, M.D. (IRB Number: NA_00073552)
Healthy Volunteers/Methamphetamine Users
Healthy men and women are needed for a 4-day inpatient study. Volunteers should be between the ages of 18-45 and in good general health. The study involves neuropsychological questionnaires and brain imaging scans. Testing will take place at Johns Hopkins Bayview Medical Center and Johns Hopkins Hospital. Volunteers will be paid for completion of all study procedures. Earn up to $450 plus travel expenses. For more information please call 410-550-6266 or 410-550-2588 or email [email protected]. Principal Investigator: Una D. McCann, M.D. (IRB Number: NA_00031313)
Healthy Brain and Imaging
PET Scans of Healthy Volunteers Over 60 Years of Age
We are conducting brain imaging research using a technique called Positron Emission Tomography, or PET for short, to take pictures of the brain. If you are in good health and aren’t taking medications that affect the brain, you may qualify for participation. Qualified people will participate at no cost to them. Compensation for time and transportation will be provided. For more information, please call: (410) 550-9052. Principal Investigator: Gwenn Smith, PhD (IRB Protocol No: NA_00021615).
Children and Adolescents
More studies with children and adolescent participants »
Assessment of Disorders of Consciousness in Children: Development of the Pediatric Coma Recovery Scale - Ages 6 months –5 years
Dr. Beth Slomine and colleagues at the Brain Injury Clinical Research Center at Kennedy Krieger Institute are recruiting children between the ages of 6 months and 5 years to participate in a research study to help better understand the responses of young children with severe brain injuries. If enrolled in this research study, the child will be asked to look at, listen to, and touch toys. This one time visit will take about 60 minutes and will take place at the Kennedy Krieger Institute at the 707 N. Broadway building. There are no significant risks or direct medical benefits for participating in this study. Each family will receive a $25.00 gift card for completing testing. If interested please contact Rachel Nicholson at 443-923-7987 or [email protected]. (IRB #: IRB00064686) Principal investigator: Dr. Beth Slomine DOWNLOAD FLYER
Neural Markers of Concussion and Recovery - Ages 13–17
Dr. Stacy Suskauer and colleagues at the Brain Injury Clinical Research Center at Kennedy Krieger Institute are recruiting teenagers between the ages of 13 and 17 years to participate in a research study examining differences in brain and behavior between participants with acute concussion and normal controls. We are looking for teenagers without any history of traumatic brain injury, including concussion, as “comparison subjects.” Participants must speak English fluently and not have any learning or mental health diagnoses. The study involves paper and pencil tasks, sensory motor tasks, computer activities and a Magnetic Resonance Imaging (MRI) of the brain. None of these tests are harmful or painful. There are no direct medical benefits from taking part in the study. The study involves two days of testing; the MRI will take place during the first visit. Participants will receive $50.00 for each study visit and a picture of their brain. Parents will receive a report of the tests administered to their child as well as the MRI results. All testing is done free of charge. For more information about this study, please contact Rachel Nicholson at 443-923-7987 or by email [email protected]. (IRB protocol #NA_00077748) Principal Investigator: Stacy Suskauer, M.D. DOWNLOAD FLYER
Iron Status and ADHD - Children ages 6–10
Dr. Rhoda Gottfried and colleagues at the Kennedy Krieger Institute are recruiting children between the ages of 6 and 10, with and without ADHD, to participate in a research study investigating Iron Status, Limb Movements, and ADHD. What to expect from participating: 1) One diagnostic interview, 2) One blood draw, 3) Brief Neurocognitive testing, 4) Three nights of wearing a device that measures leg movement. What are the benefits to participants? Participants receive a summary of the neurocognitive evaluation including an IQ score and laboratory results.Reimbursement for time and inconvenience is $100. Those interested in participation should contact research assistant Kyla Machell at 410-614-3317 or PI Rhoda Gottfried at 410-614-3469. (IRB Protocol #NA_00030898). DOWNLOAD FLYER.
Emotional Attention and Memory in Healthy Children
We are searching for healthy, typically developing children ages 7 to 17 and their parents to take part in a research study at the Kennedy Kreiger Institute/Johns Hopkins Hospital. Participation involves a psychological evaluation with the parent and child, a brief measurement of the child's IQ, and a computer test to see how children react to different faces and words. The study requires one two and half hour visit. There are no direct benefits to the child for participating in this study. There are no significant medical risks associated with the study. Roma Vasa, M.D. is the principal investigator. Call 443-923-2643. (IRB Protocol # NA_00004616) DOWNLOAD FLYER
Notice to Researchers: If you are faculty in the Department of Psychiatry and Behavioral Sciences and you wish to post a recruitment ad on this page, please contact Benedicta Kim at [email protected]. You will need to send the IRB-approved recruitment language in paragraph form with a title of the study, the PI, contact information and the IRB Protocol Number. If you wish to make a flyer available to the public, send it in PDF or Word document form. You are responsible for IRB approval of the ad. Please be sure to contact us to remove the ad from this page when recruitment is complete. Thank you.